A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
COVID-19, which has affected the lives of people worldwide, has also caused a drop in the life expectancy in India by almost two years, a statistical analysis by scientists of the city-based International Institute for Population Studies (IIPS) said.